Cell line development at BPI 2026

47 organizations at BPI 2026 present work in cell line development: 34 suppliers and service providers, 9 drug developers and 4 academic, government and non-profit bodies. Between them they bring 101 presentations to the program. Most represented: Bristol Myers Squibb (13 on the program), Pfizer (11 on the program), Merck (9 on the program). 40 of them have their own page in this guide.

All 346 organizations at BPI 2026 →

Format
Top represented
Showing 1–4 of 47 organizations
OrganizationBPI 2026 Attendance
Bristol Myers Squibb
Princeton, New Jersey
2 Senior Scientist · 1 Scientific Director, Global Upstream and Cell Line Development · 1 Principal Scientist, Cell Line Development & ‘Omics Biologics Development · 1 Scientist, Biologics Development · 8 other speakers
Large pharma
Global pharmaceutical company developing and manufacturing biologics and cell therapies.
Talk
Tue Sep 22
9:00am–9:30am
FEATURED PRESENTATION: Challenges and Emerging Approaches in Upstream Process Development: Productivity, Product Quality, and Modeling
Symposia 2: Intensified & Continuous Manufacturing
Chair
Wed Sep 23
8:55am–9:00am
Chairperson's Opening Remarks
Cell Line Development & Engineering
Talk
Wed Sep 23
9:30am–10:00am
Advancing At-Line Analytics Through a Structured PAT Roadmap: An Industrial Case Study
Digital Biomanufacturing and Data Driven Operations
Chair
Wed Sep 23
1:55pm–2:00pm
Chairperson's Remarks
Cell Line Development & Engineering
Talk
Wed Sep 23
2:00pm–2:30pm
Fast Tracking CHO Cell Line Development Using Integrated Engineering Strategies
Cell Line Development & Engineering
Panel
Wed Sep 23
2:30pm–3:00pm
PANEL DISCUSSION: Sensors for Robust Upstream Processes – When Sensors Help and When To Stop
Cell Culture & Upstream Processing · with Hamilton Company, AbbVie, HINA Bioventures
Talk
Thu Sep 24
11:45am–12:30pm
Designing for the Unknown: How Do You Plan CGT Manufacturing Facilities When the Patient Count is a Moving Target?
Development of Emerging Cell & Gene Therapies · with Hart Companies, Chrysalis, Genetix Biotherapeutics
Talk
Thu Sep 24
2:15pm–2:45pm
An Integrated Analytical Control Strategy - Execution Roadmap to Support Automation for Cell Therapies
Cell Therapy Manufacturing & Analytics
Talk
Thu Sep 24
2:45pm–3:15pm
Talk
Thu Sep 24
5:00pm–5:30pm
Fireside Chat: What Actually Changed Upstream in the Last 5 Years?
Cell Culture & Upstream Processing · with ATCC, BioProcess International
Chair
Fri Sep 25
8:50am–9:00am
Chair
Digital Biomanufacturing and Data Driven Operations
Talk
Fri Sep 25
9:00am–10:00am
Fireside Chat: New Modalities, Old Playbook: Are Multispecifics and Gene Therapy Cell Lines Stuck in mAb Thinking?
Cell Line Development & Engineering · with Pfizer, Prolific Machines, Johnson & Johnson
Talk
Fri Sep 25
9:30am–10:00am
Accelerating Biologics Process Analytics through End-to-End Sample Testing Automation
Digital Biomanufacturing and Data Driven Operations
Talk
Fri Sep 25
11:15am–11:45am
Right-First-Time Cell Line Development: Speed, Productivity, and Quality by Design
Cell Line Development & Engineering
Talk
Fri Sep 25
11:45am–12:15pm
A Solubility‑Enabled Tyrosine Delivery Strategy for Robust Biologics Manufacturing
Cell Culture & Upstream Processing
Panel
Fri Sep 25
2:30pm–3:30pm
PANEL DISCUSSION: Precision Cell Line Engineering for Biologics: Focused Innovations and Applications
Cell Line Development & Engineering · with OptiGenomics, SynGenSys, Pfizer
Panel
Fri Sep 25
2:30pm–3:30pm
PANEL DISCUSSION: The Future of Facilities: Enabling Autonomous Bioprocessing
Digital Biomanufacturing and Data Driven Operations · with Biopharma Consulting Solutions, LabScale AI, Kozyrytska Consulting +3 more
Pfizer
New York, New York
1 Senior Scientist · 1 Scientist, Purification Process Development · 1 Postdoctoral Fellow, Upstream Processing · 1 Bioprocessing Expert · 7 other speakers
Large pharma
Global pharmaceutical company developing and manufacturing medicines, vaccines and biologics, with in-house bioprocess research and development.
Talk
Tue Sep 22
11:00am–11:30am
Engineering a Scalable Platform Through Optimized N-1 Perfusion paired with Intensified Fed-Batch Processing
Symposia 2: Intensified & Continuous Manufacturing
Talk
Wed Sep 23
11:15am–11:45am
Talk
Wed Sep 23
12:15pm–12:45pm
Boosting Productivity with Intensified N 1 Perfusion and High-Seed HILVOP Operation
Cell Culture & Upstream Processing
Chair
Thu Sep 24
11:25am–11:30am
Chairperson Remarks
Cell Line Development & Engineering
Talk
Thu Sep 24
11:30am–12:00pm
Metabolic Engineering of CHO Cells Towards Cysteine Prototrophy and Systems Analysis of The Ensuing Phenotype
Cell Line Development & Engineering
Chair
Thu Sep 24
2:10pm–2:15pm
Chairperson's Remarks
Cell Line Development & Engineering
Chair
Thu Sep 24
2:10pm–2:15pm
Chairperson's Remarks
Digital Biomanufacturing and Data Driven Operations
Talk
Thu Sep 24
2:45pm–3:15pm
From Prediction to Control: Tuning Lactate Metabolism Using Raman Enabled Automated Lactate Control
Cell Culture & Upstream Processing
Talk
Fri Sep 25
9:00am–10:00am
Fireside Chat: New Modalities, Old Playbook: Are Multispecifics and Gene Therapy Cell Lines Stuck in mAb Thinking?
Cell Line Development & Engineering · with Bristol Myers Squibb, Prolific Machines, Johnson & Johnson
Keynote
Fri Sep 25
9:30am–10:00am
KEYNOTE: Engineering ADC Success from the Start: The Critical Role of Cell Culture
Cell Culture & Upstream Processing
Panel
Fri Sep 25
10:40am–11:20am
PANEL: What is AI Ready Data?
Innovation and Community Stage (Exhibit Hall) · with BioPhorum, Vertex Pharmaceuticals
Digital Biomanufacturing & AI
Panel
Fri Sep 25
2:30pm–3:30pm
PANEL DISCUSSION: Precision Cell Line Engineering for Biologics: Focused Innovations and Applications
Cell Line Development & Engineering · with OptiGenomics, SynGenSys, Bristol Myers Squibb
Merck
Rahway, New Jersey
5 Senior Scientist · 2 Associate Principal Scientist · 1 Director · 1 R&D Information Architect and Data Strategy
Large pharma
Global pharmaceutical company (Merck & Co., known as MSD outside the US and Canada) developing and manufacturing medicines, vaccines and biologics.
Chair
Tue Sep 22
8:50am–9:00am
Extended Chairperson’s Workshop Opening
Symposia 2: Intensified & Continuous Manufacturing
Talk
Tue Sep 22
1:00pm–1:30pm
Talk
Wed Sep 23
11:45am–12:15pm
Talk
Wed Sep 23
2:30pm–3:00pm
Chair
Thu Sep 24
11:25am–11:30am
Chairperson Remarks
Downstream Processing
Chair
Thu Sep 24
2:10pm–2:15pm
Chairperson's Remarks
Downstream Processing
Talk
Thu Sep 24
4:30pm–5:00pm
AI-assisted foam control in benchtop bioreactors
Cell Culture & Upstream Processing
Talk
Fri Sep 25
11:15am–11:45am
Upstream Matters for ADCs: Locking High-Performance Upstream to Simplify Downstream
Cell Culture & Upstream Processing
Panel
Fri Sep 25
11:45am–12:15pm
How should we begin to approach fully Digital Tech Transfer
CDMO Partnering & External Manufacturing · with Dassault Systèmes
Talk
Fri Sep 25
2:30pm–3:30pm
PANEL DISCUSSION: Shared Pain Points Between Upstream and Downstream Processes
Cell Culture & Upstream Processing · with AstraZeneca, LumaCyte, CUVIA +2 more
Talk
Fri Sep 25
2:30pm–3:30pm
Room 312: PANEL DISCUSSION: Shared Pain Points Between Upstream and Downstream Processes
Downstream Processing · with AstraZeneca, LumaCyte, CUVIA +2 more
AbbVie
North Chicago, Illinois
1 Principal AI Engineer · 1 Senior Scientist II · 1 Principal Research Scientist, · 1 Principal Scientist · 1 other speaker
Large pharma
Global pharmaceutical company developing and manufacturing biologics, including antibodies and antibody-drug conjugates.
Chair
Wed Sep 23
8:55am–9:00am
Chairperson's Opening Remarks
Digital Biomanufacturing and Data Driven Operations
Talk
Wed Sep 23
11:15am–11:45am
Advancing Raman chemometric models: A path to scalable and reliable bioprocess real-time monitoring and control
Digital Biomanufacturing and Data Driven Operations
Chair
Wed Sep 23
1:55pm–2:00pm
Chairperson Remarks
Digital Biomanufacturing and Data Driven Operations
Panel
Wed Sep 23
2:30pm–3:00pm
PANEL DISCUSSION: Sensors for Robust Upstream Processes – When Sensors Help and When To Stop
Cell Culture & Upstream Processing · with Bristol Myers Squibb, Hamilton Company, HINA Bioventures
Talk
Thu Sep 24
4:30pm–5:00pm
Developing a Robust Lyophilization Process for Manufacturing a Bispecific Antibody Drug Product
CMC Strategy & Manufacturing Performance
Talk
Fri Sep 25
11:45am–12:15pm
Agility and Robustness by Design: Rethinking the Process Validation Lifecycle
CMC Strategy & Manufacturing Performance
Talk
Fri Sep 25
2:00pm–2:30pm
Genetic Characterization in Cell Line Development: What Matters Most in Practice Today
Cell Line Development & Engineering

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers in cell line development

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse BPI 2026 by

Exhibit hall

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction